Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-26 @ 2:14 AM
Study NCT ID:
NCT07015905
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2025-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-12
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-03
First Submit QC Date:
None
Study First Post Date:
2025-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED